Clinical quality management in rheumatoid arthritis (RA) aims at reducing i
nflammatory activity and pain in the short term and damage and disability i
n the long term. In the "Swiss Clinical Quality Management in rheumatoid ar
thritis" (SCQM) project, which started in 1997, a measurement-improvement s
ystem with feedback reports allows the rheumatologists to follow their RA p
atients with the aim of improving the quality of outcome. Inflammatory acti
vity is measured with the Disease Activity Score (DAS28) and the Rheumatoid
Arthritis Disease Activity Index questionnaire (RADAI), damage with an X-r
ay score and disability with the Stanford Health Assessement Questionnaire
(HAQ). The feedback is used by the individual rheumatologist to optimize th
e therapy of his/her RA patients.
Beside the aim of improving the quality of treatment, the SCQM projects wan
ts to build a Swiss cohort of RA patients, to improve the collaboration of
rheumatologists in the clinic and in practice and to establish standards of
treatment in RA.
In this paper we describe the SCQM project in detail, we show two cases ill
ustrating the usefulness of the SCQM in the management of individual RA pat
ients, and we present the cross sectional analysis of the first 1223 RA pat
ients included in the project.